Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid

Basic and Clinical Pharmacology and Toxicology

Volumn 115, Issue 2, 2014, Pages 216-221

  Almutawaa, Walaa ^a   Kang, Na Hyea ^a   Pan, Yi ^a   Niles, Lennard P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CDNF PROTEIN, MOUSE; GDNF PROTEIN, MOUSE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HISTONE DEACETYLASE INHIBITOR; MANF PROTEIN, MOUSE; MESSENGER RNA; NERVE GROWTH FACTOR; TRANQUILIZER; VALPROIC ACID;

ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; NEURAL STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALS; ANTIMANIC AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HISTONE DEACETYLASE INHIBITORS; MICE; NERVE GROWTH FACTORS; NEURAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; VALPROIC ACID;

EID: 84904405914     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12201     Document Type: Article

References (30)

1. Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013;14:7-23.
2. Duarte EP, Curcio M, Canzoniero LM, Duarte CB. Neuroprotection by GDNF in the ischemic brain. Growth Factors 2012;30:242-57.
3. Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 2013;138:155-75.
4. Rossignol J, Fink K, Davis K, Clerc S, Crane A, Matchynski J et al. Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease. Stem Cells 2013;. doi:10.1002/stem.1508[Epub ahead of print].
5. Niles LP, Sathiyapalan A, Bahna S, Kang NH, Pan Y. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int J Neuropsychopharmacol 2012;16:1-8.
6. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH. Histone deacetylase inhibition mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 2004;101:16659-64.
7. Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2009;2:95-109.
8. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276:36734-41.
9. Gotfryd K, Hansen M, Kawa A, Ellerbeck U, Nau H, Berezin V et al. The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities. Basic Clin Pharmacol Toxicol 2011;109:164-74.
10. Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 2013;65:105-42.
11. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003;181:115-29.
12. Niles LP, Armstrong KJ, Rincon CL, Dao CV, Sharma R, McMillan CR et al. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004;5:41.
13. Sharma R, Ottenhof T, Rzeczkowska PA, Niles LP. Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. J Pineal Res 2008;45:277-84.
14. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992;68:33-51.
15. Kim B, Rincon Castro LM, Jawed S, Niles LP. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. Eur J Pharmacol 2008;589:45-8.
16. Airavaara M, Voutilainen MH, Wang Y, Hoffer B. Neurorestoration. Parkinsonism Relat Disord 2012;18(Suppl. 1):143-6.
17. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001;158:100-6.
18. Kong X, Li X, Cai Z, Yang N, Liu Y, Shu J et al. Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell Mol Neurobiol 2008;28:569-79.
19. Sotthibundhu A, Phansuwan-Pujito P, Govitrapong P. Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone. J Pineal Res 2010;49:291-300.
20. Glembotski CC, Thuerauf DJ, Huang C, Vekich JA, Gottlieb RA, Doroudgar S. Mesencephalic astrocyte-derived neurotrophic factor protects the heart from ischemic damage and is selectively secreted upon sarco/endoplasmic reticulum calcium depletion. J Biol Chem 2012;287:25893-904.
21. Zhao H, Liu Y, Cheng L, Liu B, Zhang W, Guo YJ et al. Mesencephalic astrocyte-derived neurotrophic factor inhibits oxygen-glucose deprivation-induced cell damage and inflammation by suppressing endoplasmic reticulum stress in rat primary astrocytes. J Mol Neurosci 2013;51:671-8.
22. Lee JY, Maeng S, Kang S, Choi HY, Oh TH, Ju BG et al. Valproic acid protects motor neuron death by inhibiting oxidative stress and ER stress-mediated cytochrome c release after spinal cord injury. J Neurotrauma 2014 [Epub ahead of print].
23. Shim JW, Park CH, Bae YC, Bae JY, Chung S, Chang MY et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007;25:1252-62.
24. Knapska E, Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol 2004;74:183-211.
25. Adachi K, Suemori H, Yasuda SY, Nakatsuji N, Kawase E. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 2010;15:455-70.
26. Castro LM, Gallant M, Niles LP. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 2005;95:1227-36.
27. Moschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher AJ et al. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev 2013;22:444-58.
28. Bang WS, Kim KT, Cho DC, Kim HJ, Sung JK. Valproic acid increases expression of neuronal stem/progenitor cell in spinal cord injury. J Korean Neurosurg Soc 2013;54:8-13.
29. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 2008;11:1123-34.
30. Yu IT, Park JY, Kim SH, Lee JS, Kim YS, Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009;56:473-80.